Edoxaban Management in Diagnostic and Therapeutic Procedures

Trial Profile

Edoxaban Management in Diagnostic and Therapeutic Procedures

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Aug 2017

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Atrial fibrillation; Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms EMIT-AF/VTE
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 08 Dec 2016 According to a Daiichi Sankyo Company media release, first patient has been enrolled in this trial.
    • 08 Dec 2016 Status changed from not yet recruiting to recruiting, as reported in a Daiichi Sankyo Company media release.
    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top